genprowebdirectory
GEN Edge
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Latest News
Login
Subscribe
News
Alzheimers
Alzheimer’s Could Lie in the Eyes of the Holder
Alzheimers
Neuronal Code for How Humans Negotiate Their Environment Identified
Cancer
Novel Cancer Therapeutic Target Found in Mitochondrial Enzyme
Cancer
Pancreatic Cancer May Succumb to “Dual Cell” Approach
Inflammatory Diseases
Food Dyes Cause Colitis When Immune System is Dysregulated, Mouse Study…
Insights
All
Trends for 2020
Trends for 2021
COVID-19 Candidates
Eminent MIT Scientists Defend Controversial SARS-CoV-2 Genome Integration Results
Bioprocessing
Aiming Cancer Computations at COVID-19
Bioprocessing
Cell and Gene Therapy Sector Looking for Non-Viral Transfection Tech
Bioprocessing
Try Capacitive Density Sensors
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Life Sciences Jobs Most in Demand over the Next…
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
A-Lists
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Merck & Co
Merck & Co
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Merck & Co
‘Manufacturing-First Approach’ Pays Off for Cell Therapy Developer Artiva
Merck & Co
Merck Halves COVID-19 Pipeline; Halts Two Vaccines, Continues Two Drugs
Merck & Co
Merck & Co. to Acquire VelosBio for $2.75B, Expanding Cancer Pipeline
Merck & Co
Merck & Co. Commits Up to $4.2B toward Seattle Genetics Cancer Partnerships
Merck & Co
As Pressure Mounts, CEOs Commit to Science, Safety in Developing COVID-19 Vaccines
Merck & Co
COVID-19 Triple Play: Merck Acquiring Themis, Partnering with Ridgeback, IAVI
Merck & Co
Merck & Co. Partnering with ISB to Study Targets for COVID-19...
Merck & Co
Merck & Co. Launches Up-to-$2.5B Cancer Collaboration with Taiho, Astex
Merck & Co
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen...
Merck & Co
Merck Acquires TRPML1 Agonist Developer Calporta for Up to $576M
Merck & Co
Merck & Co. Eliminating 500 U.S. Sales, Commercial Jobs
Merck & Co
Merck & Co. Partners with Themis on Measles Virus Vector-Based Vaccines
Merck & Co
Merck & Co., Skyhawk Collaborate on RNA-Binding Small Molecule Therapies
Merck & Co
Merck & Co. Expands Pipeline in Cancer, Fibrosis, Autoimmune Diseases by...
Merck & Co
Merck & Co. to Acquire Peloton for Up to $2.2B, Adding...
1
2
3
4
Page 1 of 4
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
